Table 6.

Comparison of adipokine serum levels at study entry in patients with or without disease progression

	Total patients (N = 147)	Progressed (N = 47)	Not progressed (N = 100)	p-value
Leptin, ng/mL	6.60 [4.20–11.70]	6.40 [3.60–10.70]	6.85 [4.33–12.33]	0.160
Adiponectin, μg/mL	9.58 [6.65–11.88]	10.10 [7.18–13.67]	9.27 [6.52–11.75]	0.337
Leptin/adiponectin ratio, ng/μg	0.76 [0.39–1.44]	0.58 [0.39–1.24]	0.94 [0.42–1.60]	0.089
Leptin/total body fat, ng/mL/kg	0.56 [0.40–0.75]	0.60 [0.43–0.82]	0.53 [0.37–0.72]	0.086
Adiponectin/total body fat, μg/mL/kg	0.72 [0.44–1.15]	0.82 [0.63–1.26]	0.60 [0.38–1.11]	0.020

Data are presented as median [interquartile range]